| |
PDF |
Real
Audio |
 Word |
 PowerPoint |
| CDC
Responds: Update on Options for Preventive Treatment
for Persons at Risk for Inhalational Anthrax December
21, 2001 |
Transcript
in PDF (198 KB/21 pages) |
Watch
the webcast |
|
|
| Opening
statements: Jim Hughes |
PDF
(548 KB/2 pages)
|
|
Word
(23 KB/2 pages) |
|
| Speaker
1: Brad Perkins --- Rationale for 3 treatment
options (including antibiotic efficacy and vaccine efficacy) |
PDF
(556 KB/16 pages)
|
|
|
PowerPoint
(1.79 MB/16 slides) |
| Speaker
2: Jai Lingappa --- Explanation and protocol
for Anthrax vaccine option (including IND, and consent
issues) |
PDF
(268 KB/12 pages)
|
|
|
PowerPoint
(1.79 MB/12 slides) |
| Speaker
3: Nancy Rosenstein --- Adherence and adverse
events associated with post-exposure chemoprophylaxis |
PDF
(345 KB/14 pages)
|
|
|
PowerPoint
(214 KB/14 slides) |
| Speaker
4: Julie Gerberding --- Summary of treatment
options (what we do/do not know) |
PDF
(399 KB/16 pages)
|
|
|
PowerPoint
(189 KB/16 slides) |
Top of Page
